Vol. 21/No. 10 | OncologyLive

Chasing a Cure for GBM: Investigators Test Multiple Regimens in Novel Trial

May 14, 2020

Columns

Investigators of the first global adaptive phase 2/3 GBM Adaptive Global Innovative Learning Environment platform trial are implementing a multiarm, 2-stage approach to concurrently evaluate single-agent and combination regimens in glioblastoma.

Looking Forward to a New Wave of Breast Cancer Therapies

May 14, 2020

Cover Story

The degree to which nature and nurture affect disease has long been debated in medicine, and it is an issue that esteemed breast cancer researcher and medical oncologist Joyce A. O’Shaughnessy, MD, has been working to unravel for her patients throughout a career that spans more than 30 years.

Robot-Assisted Cystectomy Is Feasible for Many Patients With Bladder Cancer

May 11, 2020

Partner Perspective

To determine the 10-year oncologic outcomes and recurrence patterns after robot-assisted radical cystectomy, a group within the Department of Urology at Roswell Park Comprehensive Cancer Center performed a retrospective review.

Scoring System Stratifies Risk of Heart Failure in Patients With Acute Leukemia

May 18, 2020

Feature Article

Baseline clinical characteristics coupled with measurable cardiac parameters can be used to predict the risk of heart failure among adults with acute leukemia who receive anthracycline-based therapy, according to recent study findings.

Community Oncology Practices Offer Telehealth Tips

May 13, 2020

Features

The need to adapt effectively and provide consistent care to patients with cancer during the public health threat caused by coronavirus disease 2019 has prompted the expanded use of telehealth.

Chemotherapy Findings Help Clarify Sequencing Options in mCRPC

May 13, 2020

Clinical Insights

Although numerous therapies have been introduced for patients with metastatic castration-resistant prostate cancer, the question of how to optimally sequence treatments for those who experience progression remains a vexing clinical challenge.

Oncology Clinical Trials Should Reflect Molecular Advances, Real-World Patients

May 11, 2020

From the Editor

From the earliest moments of medical school instruction, through residency and fellowship training, physicians are taught the primacy of the randomized phase 3 trial in the hierarchy of evidence-based medicine.

x